Finance

Lists
Why is AIM up 3.82%?
Dive Deeper
AIM:NYSEAMERICAN
AIM ImmunoTech Inc
$ 0.14
+3.82%
(+0.0050) 1D
$ 0.14
+2.28% (+0.0031)
After hours
Closed: 11-р сарын 17, 16:00:00 (GMT-5)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AIM...
Open
$ 0.13
High
$ 0.14
Low
$ 0.13
Mkt. cap
5.47 сая
Avg. vol.
541.91 мян
Volume
496.89 мян
52-wk high
$ 1.88
52-wk low
$ 0.12
EPS
-$ 2.46
Beta
1.32
Shares outstanding
39.92 сая
No. of employees
20
Open
$ 0.13
High
$ 0.14
Low
$ 0.13
Mkt. cap
5.47 сая
Avg. vol.
541.91 мян
Volume
496.89 мян
52-wk high
$ 1.88
52-wk low
$ 0.12
EPS
-$ 2.46
Beta
1.32
Shares outstanding
39.92 сая
No. of employees
20
News stories
From web sources and news partners
Profile
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
About AIM ImmunoTech Inc
CEO-
Employees20
Founded1966
HeadquartersФиладельфия, Пеннсилвани, Америкийн Нэгдсэн Улс
SectorHealth Care
Industry-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
21.00 мян
22.00 мян
26.00 мян
22.00 мян
Cost of goods sold
40.00 мян
4.00 мян
5.00 мян
7.00 мян
Cost of revenue
40.00 мян
4.00 мян
5.00 мян
7.00 мян
Research and development expenses
999.00 мян
381.00 мян
589.00 мян
846.00 мян
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.93 сая
1.86 сая
2.94 сая
2.13 сая
Operating expense
2.93 сая
2.24 сая
3.53 сая
2.97 сая
Total operating expenses
2.97 сая
2.25 сая
3.54 сая
2.98 сая
Operating income
-2.95 сая
-2.23 сая
-3.51 сая
-2.96 сая
Other non operating income
-942.00 мян
-500.00 мян
-
74.00 мян
EBT including unusual items
-4.18 сая
-3.02 сая
-3.79 сая
-3.14 сая
EBT excluding unusual items
-4.18 сая
-3.02 сая
-3.79 сая
-3.14 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.18 сая
-3.02 сая
-3.79 сая
-3.14 сая
Net profit margin
-19,880.95%
-13,740.91%
-14,569.23%
-14,286.36%
Earnings per share
-0.44
-0.69
-0.43
-0.21
Interest and investment income
110.00 мян
8.00 мян
21.00 мян
-
Interest expense
-391.00 мян
-304.00 мян
-295.00 мян
-259.00 мян
Net interest expenses
-281.00 мян
-296.00 мян
-274.00 мян
-259.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.91 сая
-2.18 сая
-2.98 сая
-2.68 сая
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google аппс